• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4+Foxp3+ 调节性 T 细胞中神经纤毛蛋白 1 缺乏可抑制小鼠黑色素瘤生长。

Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.

机构信息

Institute of Medical Microbiology, University Hospital Essen, University Duisburg-Essen, 45122 Essen, Germany.

出版信息

J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.

DOI:10.1084/jem.20111497
PMID:23045606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3478934/
Abstract

Infiltration of Foxp3(+) regulatory T (T reg) cells is considered to be a critical step during tumor development and progression. T reg cells supposedly suppress locally an effective anti-tumor immune response within tumor tissues, although the precise mechanism by which T reg cells infiltrate the tumor is still unclear. We provide evidence that Neuropilin 1 (Nrp-1), highly expressed by Foxp3(+) T reg cells, regulates the immunological anti-tumor control by guiding T reg cells into the tumor in response to tumor-derived vascular endothelial growth factor (VEGF). We demonstrate for the first time that T cell-specific ablation of Nrp-1 expression results in a significant breakdown in tumor immune escape in various transplantation models and in a spontaneous, endogenously driven melanoma model associated with strongly reduced tumor growth and prolonged tumor-free survival. Strikingly, numbers of tumor-infiltrating Foxp3(+) T reg cells were significantly reduced accompanied by enhanced activation of CD8(+) T cells within tumors of T cell-specific Nrp-1-deficient mice. This phenotype can be reversed by adoptive transfer of Nrp-1(+) T reg cells from wild-type mice. Thus, our data strongly suggest that Nrp-1 acts as a key mediator of Foxp3(+) T reg cell infiltration into the tumor site resulting in a dampened anti-tumor immune response and enhanced tumor progression.

摘要

Foxp3(+) 调节性 T(Treg)细胞的浸润被认为是肿瘤发展和进展过程中的一个关键步骤。Treg 细胞据称会在肿瘤组织内抑制局部有效的抗肿瘤免疫反应,尽管 Treg 细胞浸润肿瘤的确切机制仍不清楚。我们提供的证据表明,高表达于 Foxp3(+) Treg 细胞的神经纤毛蛋白 1(Nrp-1)通过引导 Treg 细胞进入肿瘤来调节免疫性抗肿瘤控制,以响应肿瘤衍生的血管内皮生长因子(VEGF)。我们首次证明,T 细胞特异性 Nrp-1 表达的缺失会导致各种移植模型中的肿瘤免疫逃逸显著破坏,以及与肿瘤生长明显减少和无肿瘤存活时间延长相关的自发、内源性驱动的黑色素瘤模型。引人注目的是,肿瘤内浸润的 Foxp3(+) Treg 细胞数量显著减少,同时 T 细胞特异性 Nrp-1 缺陷小鼠肿瘤内的 CD8(+) T 细胞激活增强。这种表型可以通过从野生型小鼠中过继转移 Nrp-1(+) Treg 细胞来逆转。因此,我们的数据强烈表明,Nrp-1 作为 Foxp3(+) Treg 细胞浸润肿瘤部位的关键介质,导致抗肿瘤免疫反应减弱和肿瘤进展增强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/e0f7aa6ec127/JEM_20111497_Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/fd551f090dc4/JEM_20111497_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/22f3230055ef/JEM_20111497_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/b820c8c5cd08/JEM_20111497_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/4ca7a72ab803/JEM_20111497_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/cbca66e57b4c/JEM_20111497_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/8a3006331732/JEM_20111497_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/424c2d0ea44f/JEM_20111497_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/51dab99e2287/JEM_20111497_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/9d80b3d07815/JEM_20111497_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/e0f7aa6ec127/JEM_20111497_Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/fd551f090dc4/JEM_20111497_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/22f3230055ef/JEM_20111497_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/b820c8c5cd08/JEM_20111497_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/4ca7a72ab803/JEM_20111497_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/cbca66e57b4c/JEM_20111497_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/8a3006331732/JEM_20111497_Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/424c2d0ea44f/JEM_20111497_Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/51dab99e2287/JEM_20111497_Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/9d80b3d07815/JEM_20111497_Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0d6/3478934/e0f7aa6ec127/JEM_20111497_Fig10.jpg

相似文献

1
Neuropilin 1 deficiency on CD4+Foxp3+ regulatory T cells impairs mouse melanoma growth.CD4+Foxp3+ 调节性 T 细胞中神经纤毛蛋白 1 缺乏可抑制小鼠黑色素瘤生长。
J Exp Med. 2012 Oct 22;209(11):2001-16. doi: 10.1084/jem.20111497. Epub 2012 Oct 8.
2
Intratumoral convergence of the TCR repertoires of effector and Foxp3+ CD4+ T cells.效应性 CD4+T 细胞和 Foxp3+CD4+T 细胞中 TCR 库的肿瘤内趋同。
PLoS One. 2010 Oct 26;5(10):e13623. doi: 10.1371/journal.pone.0013623.
3
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.CD4 +辅助性T细胞增强了CD8 + T细胞对肿瘤/自身抗原的免疫反应,而天然存在的调节性T细胞则对其产生阻碍。
J Immunol. 2005 Mar 1;174(5):2591-601. doi: 10.4049/jimmunol.174.5.2591.
4
Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes promote lung fibrosis.血小板衍生生长因子产生的 CD4+Foxp3+调节性 T 淋巴细胞促进肺纤维化。
Am J Respir Crit Care Med. 2011 Dec 1;184(11):1270-81. doi: 10.1164/rccm.201103-0516OC. Epub 2011 Aug 25.
5
Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not mucosa-generated induced Foxp3+ T reg cells.神经纤毛蛋白 1 表达于胸腺来源的天然调节性 T 细胞,而不是黏膜诱导产生的 Foxp3+Treg 细胞。
J Exp Med. 2012 Sep 24;209(10):1723-42, S1. doi: 10.1084/jem.20120914. Epub 2012 Sep 10.
6
Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo.Neuropilin-1 在体内调节性 T 细胞亚群中区分天然和诱导性调节性 T 细胞。
J Exp Med. 2012 Sep 24;209(10):1713-22, S1-19. doi: 10.1084/jem.20120822. Epub 2012 Sep 10.
7
Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors.肿瘤浸润调节性 T 细胞通过 PD-1 和抑制性受体的上调来界定。
Cell Immunol. 2012 Jul-Aug;278(1-2):76-83. doi: 10.1016/j.cellimm.2012.07.001. Epub 2012 Jul 24.
8
Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction.黑色素瘤细胞中 Foxp3 的表达可能是对免疫破坏产生抵抗的机制之一。
Cancer Immunol Immunother. 2011 Aug;60(8):1109-18. doi: 10.1007/s00262-011-1025-3. Epub 2011 May 6.
9
Characterisation of Foxp3 splice variants in human CD4+ and CD8+ T cells--identification of Foxp3Δ7 in human regulatory T cells.鉴定人源 CD4+ 和 CD8+ T 细胞中 Foxp3 剪接变异体——人调节性 T 细胞中 Foxp3Δ7 的鉴定。
Mol Immunol. 2010 Nov-Dec;48(1-3):321-32. doi: 10.1016/j.molimm.2010.07.008. Epub 2010 Aug 5.
10
Differential changes in CD4+ and CD8+ effector and regulatory T lymphocyte subsets in the testis of rats undergoing autoimmune orchitis.患自身免疫性睾丸炎大鼠睾丸中CD4+和CD8+效应及调节性T淋巴细胞亚群的差异变化。
J Reprod Immunol. 2009 Jul;81(1):44-54. doi: 10.1016/j.jri.2009.04.005. Epub 2009 Jun 10.

引用本文的文献

1
Significance of a Novel Angiogenesis-Related Biomarker Neuropilin-1 in Keloids.一种新型血管生成相关生物标志物神经纤毛蛋白-1在瘢痕疙瘩中的意义
Mol Biotechnol. 2025 Jul 19. doi: 10.1007/s12033-025-01481-x.
2
Ceramide signaling in immunity: a molecular perspective.免疫中的神经酰胺信号传导:分子视角
Lipids Health Dis. 2025 Jul 1;24(1):225. doi: 10.1186/s12944-025-02642-2.
3
Neuropilin-2 functions as a coinhibitory receptor to regulate antigen-induced inflammation and allograft rejection.神经纤毛蛋白-2作为一种共抑制受体发挥作用,以调节抗原诱导的炎症和同种异体移植排斥反应。

本文引用的文献

1
Role of TGF-β in melanoma.TGF-β 在黑色素瘤中的作用。
Curr Pharm Biotechnol. 2011 Dec;12(12):2165-75. doi: 10.2174/138920111798808437.
2
Neuropilin-1 attenuates autoreactivity in experimental autoimmune encephalomyelitis.神经纤毛蛋白-1 可减轻实验性自身免疫性脑脊髓炎的自身反应性。
Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2040-5. doi: 10.1073/pnas.1008721108. Epub 2011 Jan 18.
3
Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.选择性耗竭 Foxp3+调节性 T 细胞可提高建立的黑色素瘤有效治疗性疫苗的疗效。
J Clin Invest. 2025 Jul 1;135(13). doi: 10.1172/JCI172218.
4
Neuropilin-1: A Multifaceted Target for Cancer Therapy.神经纤毛蛋白-1:癌症治疗的多面靶点
Curr Oncol. 2025 Mar 31;32(4):203. doi: 10.3390/curroncol32040203.
5
Immunomodulation by allograft endothelial cells.同种异体移植内皮细胞的免疫调节作用。
Front Transplant. 2025 Feb 4;4:1518772. doi: 10.3389/frtra.2025.1518772. eCollection 2025.
6
The complex role of regulatory cells in breast cancer: implication for immunopathogenesis and immunotherapy.调节性细胞在乳腺癌中的复杂作用:对免疫发病机制和免疫治疗的影响
Breast Cancer. 2025 Mar;32(2):227-241. doi: 10.1007/s12282-024-01654-7. Epub 2024 Nov 26.
7
Contemporaneous Inflammatory, Angiogenic, Fibrogenic, and Angiostatic Cytokine Profiles of the Time-to-Tumor Development by Cancer Cells to Orchestrate Tumor Neovascularization, Progression, and Metastasis.同期癌细胞向肿瘤新生血管、进展和转移的时间发展的炎症、血管生成、纤维生成和血管生成抑制细胞因子谱。
Cells. 2024 Oct 20;13(20):1739. doi: 10.3390/cells13201739.
8
Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects.调节性 T 细胞治疗乳腺癌的策略:整体到局部方面。
Cells. 2024 Sep 11;13(18):1526. doi: 10.3390/cells13181526.
9
Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy.肿瘤免疫微环境中浸润性调节性T细胞重编程及其免疫治疗优化
Biomark Res. 2024 Sep 4;12(1):97. doi: 10.1186/s40364-024-00630-9.
10
Regulatory T cells and immune escape in HCC: understanding the tumor microenvironment and advancing CAR-T cell therapy.调节性 T 细胞与 HCC 免疫逃逸:深入了解肿瘤微环境并推进 CAR-T 细胞治疗。
Front Immunol. 2024 Jul 29;15:1431211. doi: 10.3389/fimmu.2024.1431211. eCollection 2024.
Cancer Res. 2010 Oct 15;70(20):7788-99. doi: 10.1158/0008-5472.CAN-10-1736. Epub 2010 Oct 5.
4
Regulatory T cells in tumor immunity.肿瘤免疫中的调节性 T 细胞。
Int J Cancer. 2010 Aug 15;127(4):759-67. doi: 10.1002/ijc.25429.
5
Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma.抗血管生成治疗的耐药性由恶性黑色素瘤的血管表型、血管稳定和成熟决定。
J Exp Med. 2010 Mar 15;207(3):491-503. doi: 10.1084/jem.20091846. Epub 2010 Mar 1.
6
FcRgamma activation regulates inflammation-associated squamous carcinogenesis.FcRγ 激活调控炎症相关鳞状细胞癌发生。
Cancer Cell. 2010 Feb 17;17(2):121-34. doi: 10.1016/j.ccr.2009.12.019. Epub 2010 Feb 4.
7
Cytokine levels correlate with immune cell infiltration after anti-VEGF therapy in preclinical mouse models of breast cancer.细胞因子水平与乳腺癌临床前小鼠模型抗 VEGF 治疗后免疫细胞浸润相关。
PLoS One. 2009 Nov 3;4(11):e7669. doi: 10.1371/journal.pone.0007669.
8
The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.非小细胞肺癌患者外周血中FOXP3 + 调节性T细胞的患病率。
Cancer Biother Radiopharm. 2009 Jun;24(3):357-67. doi: 10.1089/cbr.2008.0612.
9
The contribution of vascular endothelial growth factor to the induction of regulatory T-cells in malignant effusions.血管内皮生长因子在恶性积液中诱导调节性T细胞的作用。
Anticancer Res. 2009 Mar;29(3):881-8.
10
VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.VEGF与急性和慢性MOG((35 - 55))肽诱导的实验性自身免疫性脑脊髓炎中的血管生成
J Neuroimmunol. 2009 Apr 30;209(1-2):6-15. doi: 10.1016/j.jneuroim.2009.01.009. Epub 2009 Feb 23.